PV pharm branch, vendor, cage 0U9U0
Ended Awarded Last action
- Contract number
- SPE2D826F0DAE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $26,947
Award facts
- Contract value 100% obligated
- $26,946.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $26,946.80 with an ultimate completion date of January 13, 2026, was awarded to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 12, 2026, under a firm fixed-price contract structure. The award represents a child contract issued under AmerSourceBergen's larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical, valued at up to $999,999,999.00 through December 2026. This IDC, designated SPE2DX, serves as a comprehensive global pharmaceutical support vehicle enabling AmerSourceBergen to supply a wide range of pharmaceutical products, medical supplies, vaccines, and specialized healthcare commodities to support military healthcare programs worldwide. The place of performance is Conshohocken, Pennsylvania, with funding provided by the Defense Logistics Agency's Medical Supply Chain division. No set-aside designation was applied to this competitive award.
AmerSourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerSourceBergen), is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement needs across military and veteran healthcare systems. The company's extensive portfolio includes diabetes medications, neurological treatments, pain management pharmaceuticals, antibiotics, vaccines, and specialized medical devices. All of AmerSourceBergen's reviewed contract awards have been competitively awarded through open competition, demonstrating the company's capability to meet stringent federal procurement requirements and pricing standards across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2D826F0DAE?
SPE2D826F0DAE was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on January 12, 2026.
How much is contract SPE2D826F0DAE worth?
The government has obligated $26,947 on SPE2D826F0DAE.
Is contract SPE2D826F0DAE an order under another contract?
Yes. SPE2D826F0DAE is a delivery order under SPE2DX22D0129, an indefinite delivery contract.
Was contract SPE2D826F0DAE competed?
The extent of competition for SPE2D826F0DAE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award